Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis

被引：0
|
作者：
Best, Jennie H. [1 ]
Abbass, Ibrahim [1 ]
Tominna, Lenore [1 ]
Reiss, William [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
AMERICAN HEALTH AND DRUG BENEFITS | 2020年 / 13卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：72 / 73
页数：2
相关论文
共 50 条
  • [1] Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis Response
    Punekar, Rajeshwari
    Choi, Jeannie
    Boklage, Susan H.
    Iglesias-Rodriguez, Melitza
    Nola, Kamala
    AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (02): : 73 - 73
  • [2] Real World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis
    Punekar, Rajeshwari
    Choi, Jeannie
    Boklage, Susan
    Iglesias-Rodriguez, Melitza
    Nola, Kamala
    AMERICAN HEALTH AND DRUG BENEFITS, 2019, 12 (08): : 400 - 409
  • [3] Weekly subcutaneous injection of tocilizumab in patients with rheumatoid arthritis
    Ito, Satoshi
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 17 - 19
  • [4] Utilisation of subcutaneous Tocilizumab in rheumatoid arthritis patients in Grampian
    Philobos, M.
    Davidson, A.
    Dospinescu, P.
    SCOTTISH MEDICAL JOURNAL, 2019, 64 (03) : NP39 - NP39
  • [5] Subcutaneous tocilizumab for the treatment of rheumatoid arthritis
    Mitchell, Emma
    Jones, Graeme
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (02) : 103 - 114
  • [6] Subcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis
    Ogata, Atsushi
    Morita, Takayoshi
    Yoshida, Yuji
    Tanaka, Toshio
    THERAPEUTIC DELIVERY, 2015, 6 (03) : 283 - 295
  • [7] Effect of Dose Escalation of Subcutaneous Tocilizumab on Disease Activity in Patients with Rheumatoid Arthritis in a Randomized Controlled Trial
    Singer, Nora G.
    Mohan, Shalini V.
    Yourish, Jeffrey
    Han, Jian
    Edwardes, Michael
    Michalska, Margaret
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] EFFECT OF DOSE ESCALATION OF SUBCUTANEOUS TOCILIZUMAB ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A RANDOMIZED CONTROLLED TRIAL
    Singer, N.
    Mohan, S.
    Han, J.
    Edwardes, M.
    Michalska, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1126 - 1126
  • [9] THE EFFECT OF BODYWEIGHT ON RESPONSE TO INTRAVENOUS OR SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Davies, R.
    Vivekanantham, A.
    Lunt, M.
    Watson, K.
    Hyrich, K.
    Bluett, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 981 - 981
  • [10] INDUCTION AND PROGRESSION OF SUBCUTANEOUS NODULOSIS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB
    Talotta, R.
    Batticciotto, A.
    Ditto, M. C.
    Gerardi, M. C.
    Ventura, D.
    Puttin, P. Sarzi
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1194 - 1194
12345